MRVI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $7.90

P/E (TTM) -15.2

EPS (TTM) $-0.52

Revenue (TTM) $209M

ROE (TTM) -32.9%

Debt/Equity (MRQ) 0.7

52W Range $3–$9

MRVI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Maravai LifeSciences Holdings, Inc. - Class A common stock Company overview from Wikipedia

05 · wikidata

Wikidata ↗

sectorHealthcare industryLife Sciences Tools & Services employees415 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$186M

2019-12-31 → 2025-12-31

EPS$-0.90

2019-12-31 → 2025-12-31

Free Cash Flow$-71M

2021-12-31 → 2025-12-31

Net margin-37.1%

2021-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	5Y trend	MRVI	5Y avg	Peer Median	Verdict
P/E (TTM)		-15.25Y avg ≈-5.4	≈-5.4	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	MRVI	5Y avg	Peer Median	Verdict
Gross Margin (TTM)	34.9%	·	50.6%	Weak
Operating Margin (TTM)	-56.1%5Y avg ≈-72.6%	≈-72.6%	-0.30%	Weak
EBITDA Margin	-115.9%5Y avg ≈-72.6%	≈-72.6%	-0.20%	Weak
Pretax Margin (TTM)	-65.4%5Y avg ≈-4.5%	≈-4.5%	0.17%	Weak
Net Profit Margin (TTM)	-37.1%5Y avg ≈-55.8%	≈-55.8%	-1.1%	Weak
ROA (TTM)	-10.3%5Y avg ≈-11.2%	≈-11.2%	-2.7%	Weak
ROE (TTM)	-32.9%5Y avg ≈-38.9%	≈-38.9%	-3.3%	Weak
ROIC	-41.9%5Y avg ≈-26.3%	≈-26.3%	-4.4%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	MRVI	5Y avg	Peer Median	Verdict
Debt / Equity (MRQ)	0.75Y avg ≈1.2	≈1.2	0.7	In line
Current Ratio (MRQ)	4.15Y avg ≈7.4	≈7.4	3.4	Strong liquidity
Quick Ratio	5.45Y avg ≈6.3	≈6.3	2.3	Strong liquidity
Long-Term Debt / Equity (MRQ)	0.75Y avg ≈1.2	≈1.2	0.7	In line

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	MRVI	5Y avg	Peer Median	Verdict
Revenue YoY	-28.3%5Y avg ≈-35.3%	≈-35.3%	·	·
Revenue CAGR 3Y	-40.5%5Y avg ≈-23.8%	≈-23.8%	·	·
Revenue CAGR 5Y	-8.2%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	MRVI	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-0.905Y avg ≈$-0.95	≈$-0.95	·	·
Revenue / Share	$1.295Y avg ≈$1.79	≈$1.79	·	·
Cash Flow / Share	$-0.405Y avg ≈$0.20	≈$0.20	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	MRVI	5Y avg	Peer Median	Verdict
Asset Turnover	0.25Y avg ≈0.2	≈0.2	0.4	Weak
Inventory Turnover	3.45Y avg ≈3.2	≈3.2	3.8	In line
Receivables Turnover	5.85Y avg ≈5.5	≈5.5	5.9	In line
Revenue / Employee	≈$447.6K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 33.9%

Next Report Nov 04, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 11, 2026	$-0.02	$-0.04	54.6%
March 31, 2026	May 11, 2026	$0.01	$-0.05	120.8%
Dec. 31, 2025		$-0.04	$-0.07	44.7%
Sept. 30, 2025		$-0.08	$-0.08	4.0%
June 30, 2025		$-0.08	$-0.07	-10.7%
March 31, 2025		$-0.08	$-0.07	-9.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 18

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue	$186M	$259M	$289M	$883M	$799M	$284M	$143M
Cost of Revenue	$152M	$151M	$149M	$169M	$141M	$80M	$67M
Gross Profit	$34M	$108M	$140M	·	·	·	·
R&D Expense	$17M	$19M	$17M	$18M	$15M	$9M	$4M
SG&A Expense	$145M	$162M	$151M	$129M	$100M	$94M	$48M
Operating Expenses	$249M	$344M	$172M	$309M	$245M	$164M	$119M
Operating Income	$-215M	$-236M	$-32M	$574M	$555M	$120M	$24M
Interest Expense	·	·	$46M	$20M	$30M	$31M	$30M
Interest Income	$11M	$27M	$28M	$2M	$0	$0	·
Other Non-op	$-4M	$-2M	$-1M	$-358.0K	$279.0K	$126.0K	$118.0K
Pretax Income	$-235M	$-261M	$618M	$551M	$531M	$82M	$-6M
Income Tax	$-4M	$-2M	$756M	$61M	$62M	$3M	$-652.0K
Net Income	$-131M	$-145M	$-119M	$220M	$182M	$89M	$-4M
EPS (Basic)	$-0.90	$-1.05	$-0.90	$1.67	$1.59	$7.43	$-0.03
EPS (Diluted)	$-0.90	$-1.05	$-0.90	$1.67	$1.56	$2.36	$-0.03
Shares (Basic)	144,360,000	137,906,000	131,919,000	131,545,000	114,791,000	10,351,000	253,917,000
Shares (Diluted)	144,360,000	137,906,000	131,919,000	255,323,000	257,803,000	28,908,000	253,917,000
EBITDA	$-215M	$-236M	$-32M	$574M	$555M	·	·

Balance Sheet 25

Metric	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$217M	$322M	$575M	$632M	$551M	$236M	·
Receivables	$25M	$39M	$55M	$139M	$118M	$51M	·
Inventory	$40M	$50M	$51M	$43M	$52M	$33M	·
Prepaid Expense	$13M	$18M	$19M	$26M	$20M	$11M	·
Current Assets	$296M	$429M	$700M	$848M	$740M	$332M	·
PP&E (Net)	$151M	$164M	$163M	$53M	$46M	$101M	·
Accum. Depreciation	$68M	$53M	$32M	$20M	$13M	$11M	·
Goodwill	$129M	$160M	$326M	$284M	$153M	$224M	·
Intangibles	$152M	$195M	$221M	$217M	$118M	$178M	·
Other Non-current Assets	$42M	$60M	$78M	$116M	$53M	$4M	·
Total Assets	$771M	$1.01B	$1.49B	$2.28B	$1.92B	$1.27B	·
Accounts Payable	$3M	$12M	·	$6M	$8M	$8M	·
Accrued Liabilities	$37M	$40M	$60M	$53M	$35M	$39M	·
Current Liabilities	$45M	$57M	$87M	$110M	$94M	$131M	·
Capital Leases	$34M	$41M	$48M	$52M	$41M	$56M	·
Deferred Tax	·	$11.0K	·	$0	$0	$9M	·
Other Non-current Liabilities	$36M	$52M	$59M	$69M	$41M	$2M	·
Total Liabilities	$398M	$431M	$698M	$1.38B	$1.37B	$1.12B	·
Long-term Debt	$292M	$296M	$524M	$527M	$531M	$535M	·
Total Debt	$292M	$296M	$524M	$527M	$531M	·	·
Paid-in Capital	$199M	$182M	$129M	$138M	$128M	$85M	·
Retained Earnings	$10M	$141M	$286M	$405M	$185M	$854.0K	·
AOCI	$524.0K	$0	·	·	$0	$-44.0K	·
Stockholders' Equity	$212M	$325M	$417M	$545M	$315M	$89M	·
Liabilities + Equity	$771M	$1.01B	$1.49B	$2.28B	$1.92B	$1.27B	·

Cash Flow 16

Metric	2025	2024	2023	2022	2021	2020	2019
Stock-based Comp	$30M	$49M	$35M	$19M	$10M	$25M	$2M
Deferred Tax	$-20.0K	$11.0K	$755M	$42M	$47M	$-5M	$-1M
Amort. of Intangibles	$28M	$28M	$27M	$24M	$18M	$20M	$20M
Restructuring	$18M	$-1M	$6M	$0	$0	·	·
Operating Cash Flow	$-58M	$7M	$126M	$536M	$369M	$152M	$24M
CapEx	$13M	$30M	$66M	$17M	$15M	$25M	$17M
Investing Cash Flow	$-31M	$-24M	$-122M	$-268M	$106M	$6M	$-17M
Debt Issued	·	$953.0K	$0	$8M	$0	$609M	$0
Net Debt Issued	$-5M	$-233M	$-5M	$-5M	$-6M	·	·
Stock Repurchased	·	·	·	$0	$0	$34M	$0
Net Stock Activity	·	·	·	$0	$0	·	·
Financing Cash Flow	$-16M	$-236M	$-61M	$-187M	$-159M	$53M	$-4M
Net Change in Cash	$-106M	$-253M	$-57M	$81M	$315M	$211M	$3M
Taxes Paid	$-555.0K	$670.0K	$-3M	$23M	$22M	·	·
Free Cash Flow	$-71M	$-22M	$61M	$519M	$354M	·	·
Levered FCF	·	·	$71M	$501M	$327M	·	·

Profitability 8

Metric	2025	2024	2023	2022	2021	2020	2019
Gross Margin	18.3%	·	·	·	·	·	·
Operating Margin	-115.9%	-90.9%	-10.9%	65.0%	69.4%	·	·
Net Margin	-70.4%	-55.9%	-41.2%	24.9%	22.8%	·	·
Pretax Margin	-126.5%	-100.9%	213.8%	62.5%	66.4%	·	·
EBITDA Margin	-115.9%	-90.9%	-10.9%	65.0%	69.4%	·	·
ROA	-14.7%	-12.7%	-6.3%	10.5%	11.4%	·	·
ROE	-48.6%	-43.2%	-24.8%	51.2%	90.1%	·	·
ROIC	-41.9%	-37.7%	0.75%	47.6%	58.0%	·	·

Liquidity & Solvency 5

Metric	2025	2024	2023	2022	2021	2020	2019
Current Ratio	6.6	7.5	8.0	7.7	7.9	·	·
Quick Ratio	5.4	6.3	7.2	7.0	7.1	·	·
Debt / Equity	1.4	0.9	1.3	1.0	1.7	·	·
LT Debt / Equity	1.3	0.9	1.2	1.0	1.7	·	·
Interest Coverage	·	·	-0.7	28.1	18.3	·	·

Efficiency 3

Metric	2025	2024	2023	2022	2021	2020	2019
Asset Turnover	0.2	0.2	0.2	0.4	0.5	·	·
Inventory Turnover	3.4	3.0	3.1	3.6	3.3	·	·
Receivables Turnover	5.8	7.7	3.0	6.9	9.5	·	·

Per Share 3

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue / Share	$1.29	$1.88	$2.19	$3.46	$3.10	·	·
Cash Flow / Share	$-0.40	$0.05	$0.96	$2.10	$1.43	·	·
EPS (TTM)	$-0.90	$-1.05	$-0.90	$1.67	$1.56	$2.36	·

Growth Rates 5

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	-28.3%	-10.3%	-67.3%	10.5%	181.3%	·	·
Revenue CAGR 3Y	-40.5%	-31.3%	0.57%	·	·	·	·
Revenue CAGR 5Y	-8.2%	·	·	·	·	·	·
EPS YoY	·	·	·	7.0%	-33.9%	·	·
Net Income YoY	·	·	·	21.0%	104.6%	·	·

Valuation (TTM) 4

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$186M	$259M	$289M	$883M	$799M	$284M	·
Net Income TTM	$-131M	$-145M	$-119M	$220M	$182M	$89M	·
P/E	-3.6	-5.2	-7.3	8.6	26.9	11.9	·
Earnings Yield	-27.7%	-19.3%	-13.7%	11.7%	3.7%	8.4%	·

Income Statement 18

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$51M	$66M	$50M	$42M	$47M	$47M	$57M	$69M	$69M	$64M	$74M	$67M	$69M	$79M	$205M	$191M
Cost of Revenue	$31M	$32M	$37M	$36M	$40M	$39M	$37M	$37M	$39M	$38M	$35M	$37M	$43M	$34M	$53M	$38M
Gross Profit	$21M	$34M	$13M	$6M	$8M	$8M	$19M	$32M	·	·	·	·	·	·	·	·
R&D Expense	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$4M	$4M	$4M	$5M	$5M
SG&A Expense	$32M	$29M	$32M	$35M	$39M	$40M	$41M	$39M	$41M	$41M	$38M	$39M	$35M	$39M	$37M	$31M
Operating Expenses	$36M	$36M	$-7M	$47M	$74M	$57M	$-20M	$198M	$83M	$83M	$-67M	$82M	$81M	$76M	$95M	$74M
Operating Income	$-15M	$-2M	$-59M	$-41M	$-66M	$-49M	$-38M	$-166M	$-13M	$-19M	$-7M	$-15M	$-12M	$3M	$109M	$117M
Interest Expense	·	·	·	·	·	·	·	$14M	$12M	$11M	·	$12M	$7M	$12M	·	$3M
Interest Income	$1M	$2M	$2M	$3M	$3M	$3M	$6M	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$2M	$0
Other Non-op	$-52.0K	$-494.0K	$-43.0K	$-71.0K	$-4M	$24.0K	$43.0K	$72.0K	$-3M	$106.0K	$49.0K	$66.0K	$-2M	$168.0K	$914.0K	$-4.0K
Pretax Income	$-22M	$-7M	$-63M	$-45M	$-74M	$-53M	$-46M	$-172M	$-21M	$-22M	$656M	$-21M	$-13M	$-5M	$96M	$114M
Income Tax	$-171.0K	$-151.0K	$6.0K	$-92.0K	$-4M	$162.0K	$-7.0K	$311.0K	$-2M	$271.0K	$766M	$-5M	$-1M	$-3M	$8M	$14M
Net Income	$-12M	$-4M	$-36M	$-26M	$-40M	$-30M	$-26M	$-97M	$-10M	$-12M	$-106M	$-6M	$-7M	$-67.0K	$38M	$44M
EPS (Basic)	$-0.08	$-0.02	$-0.24	$-0.18	$-0.27	$-0.21	$-0.21	$-0.68	$-0.07	$-0.09	$-0.80	$-0.05	$-0.05	$0.00	$0.28	$0.34
EPS (Diluted)	$-0.08	$-0.02	$-0.24	$-0.18	$-0.27	$-0.21	$-0.21	$-0.68	$-0.07	$-0.09	$-0.80	$-0.05	$-0.05	$0.00	$0.30	$0.34
Shares (Basic)	147,996,000	146,426,000	·	144,683,000	144,236,000	143,425,000	·	141,555,000	135,842,000	132,333,000	·	131,930,000	131,864,000	131,739,000	·	131,540,000
Shares (Diluted)	147,996,000	146,426,000	·	144,683,000	144,236,000	143,425,000	·	141,555,000	135,842,000	132,333,000	·	131,930,000	131,864,000	131,739,000	·	131,651,000
EBITDA	$-15M	$-2M	·	$-41M	$-66M	$-49M	·	$-169M	$-10M	$-19M	·	$-15M	$-12M	$3M	·	$117M

Balance Sheet 25

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$70M	$166M	$217M	$244M	$270M	$285M	$322M	$578M	$573M	$562M	·	$580M	$580M	$628M	·	$617M
Receivables	$31M	$33M	$25M	$23M	$28M	$28M	$39M	$29M	$39M	$37M	·	$46M	$49M	$56M	·	$114M
Inventory	$41M	$40M	$40M	$45M	$47M	$50M	$50M	$50M	$49M	$50M	·	$49M	$47M	$55M	·	$62M
Prepaid Expense	$13M	$12M	$13M	$14M	$15M	$13M	$18M	$22M	$17M	$17M	·	$23M	$23M	$26M	·	$23M
Current Assets	$156M	$252M	$296M	$326M	$360M	$376M	$429M	$679M	$685M	$668M	·	$701M	$699M	$766M	·	$836M
PP&E (Net)	·	·	$151M	·	·	·	$164M	·	·	·	·	·	·	·	·	$48M
Accum. Depreciation	·	·	$68M	·	·	·	$53M	·	·	·	·	·	·	·	·	·
Goodwill	$129M	$129M	$129M	$129M	$129M	$160M	$160M	$172M	$326M	$326M	·	$326M	$326M	$327M	·	$284M
Intangibles	$138M	$145M	$152M	$186M	$193M	$200M	$195M	$202M	$207M	$214M	·	$228M	$235M	$242M	·	$223M
Other Non-current Assets	$38M	$40M	$42M	$49M	$52M	$58M	$60M	$61M	$63M	$75M	·	$86M	$93M	$127M	·	$87M
Total Assets	$604M	$713M	$771M	$849M	$897M	$960M	$1.01B	$1.28B	$1.45B	$1.44B	·	$2.27B	$2.26B	$2.32B	·	$2.25B
Accounts Payable	$7M	$9M	$3M	$8M	$12M	$10M	$12M	·	·	·	·	·	·	$5M	·	$9M
Accrued Liabilities	$30M	$29M	$37M	$48M	$50M	$45M	$40M	$38M	$41M	$35M	·	$56M	$50M	$70M	·	$60M
Current Liabilities	$38M	$43M	$45M	$62M	$70M	$63M	$57M	$63M	$69M	$59M	·	$78M	$75M	$125M	·	$116M
Capital Leases	·	·	$34M	$36M	$38M	·	$41M	·	·	·	·	$50M	$52M	$54M	·	$44M
Deferred Tax	·	·	·	·	$2M	$2M	·	·	·	·	·	$7M	$9M	$9M	·	·
Other Non-current Liabilities	$34M	$36M	$36M	$38M	$38M	$44M	$52M	$54M	$54M	$59M	·	$65M	$63M	$66M	·	$58M
Total Liabilities	$248M	$344M	$398M	$417M	$429M	$429M	$431M	$665M	$671M	$667M	·	$1.38B	$1.37B	$1.41B	·	$1.41B
Long-term Debt	$147M	$241M	$292M	$293M	$294M	$295M	$296M	$522M	$523M	$523M	·	$525M	$526M	$527M	·	$528M
Total Debt	$147M	$241M	·	$293M	$294M	$295M	·	$522M	$523M	$523M	·	$525M	$526M	$527M	·	$528M
Paid-in Capital	$208M	$202M	$199M	$197M	$191M	$187M	$182M	$176M	$168M	$134M	·	$125M	$120M	$114M	·	$134M
Retained Earnings	$-6M	$6M	$10M	$46M	$71M	$111M	$141M	$167M	$266M	$274M	·	$392M	$398M	$405M	·	$367M
AOCI	$459.0K	$466.0K	$524.0K	$579.0K	$574.0K	$324.0K	$0	·	·	·	·	·	·	·	·	·
Stockholders' Equity	$205M	$212M	$212M	$245M	$266M	$301M	$325M	$345M	$437M	$411M	·	$519M	$521M	$522M	·	$504M
Liabilities + Equity	$604M	$713M	$771M	$849M	$897M	$960M	$1.01B	$1.28B	$1.45B	$1.44B	·	$2.27B	$2.26B	$2.32B	·	$2.25B

Cash Flow 14

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$10M	$7M	$4M	$9M	$7M	$10M	$11M	$13M	$14M	$12M	$9M	$10M	$9M	$6M	$6M	$5M
Deferred Tax	·	·	·	·	·	·	$11.0K	$0	$0	$0	$765M	$-6M	$-3M	$-2M	$7M	$9M
Amort. of Intangibles	$6M	$6M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$6M
Restructuring	$-33.0K	$3M	$10M	$7M	$0	$0	$6.0K	$-4.0K	$-4.0K	$-1M	$6M	$0	$0	$0	·	·
Operating Cash Flow	$4M	$9M	$-23M	$-15M	$-10M	$-9M	$-15M	$13M	$17M	$-8M	$8M	$14M	$19M	$85M	$99M	$110M
CapEx	$370.0K	$4M	$2M	$3M	$3M	$5M	$6M	$9M	$10M	$6M	$17M	$16M	$25M	$8M	$6M	$6M
Investing Cash Flow	$-370.0K	$-4M	$-2M	$-3M	$-3M	$-23M	$-5M	$-9M	$-6M	$-4M	$-13M	$-16M	$-24M	$-70M	$-19M	$-6M
Debt Issued	·	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	$0	$0
Net Debt Issued	·	$-51M	·	·	·	$-1M	·	·	·	$-1M	·	·	·	$-1M	·	·
Financing Cash Flow	$-99M	$-55M	$-2M	$-8M	$-2M	$-5M	$-236M	$809.0K	$228.0K	$-560.0K	$470.0K	$783.0K	$-43M	$-19M	$-66M	$-37M
Net Change in Cash	$-95M	$-51M	$-27M	$-26M	$-15M	$-37M	$-256M	$5M	$11M	$-13M	$-5M	$-571.0K	$-48M	$-4M	$15M	$67M
Taxes Paid	$0	$0	$6.0K	$-26.0K	$-674.0K	$139.0K	$26.0K	$267.0K	$180.0K	$197.0K	$90.0K	$-3M	$449.0K	$-521.0K	$3M	$6M
Free Cash Flow	·	$4M	·	·	·	$-15M	·	·	·	$-14M	·	·	·	$77M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-25M	·	·	·	$74M	·	·

Profitability 8

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	40.1%	51.2%	·	13.6%	·	·	·	·	·	·	·	·	·	·	·	·
Operating Margin	-29.3%	-3.3%	·	-98.6%	-139.8%	-104.9%	·	-259.4%	-13.0%	-29.4%	·	-23.1%	-16.9%	3.2%	·	61.1%
Net Margin	-24.1%	-5.7%	·	-61.4%	-83.5%	-63.9%	·	-151.9%	-10.3%	-18.8%	·	-9.7%	-9.5%	-0.08%	·	23.2%
Pretax Margin	-42.4%	-9.9%	·	-108.5%	-156.4%	-112.5%	·	-269.4%	-23.1%	-34.9%	·	-30.8%	-19.4%	-5.7%	·	59.5%
EBITDA Margin	-29.3%	-3.3%	·	-98.6%	-139.8%	-104.9%	·	-259.4%	-13.0%	-29.4%	·	-23.1%	-16.9%	3.2%	·	61.1%
ROA	-1.7%	-0.45%	·	-2.4%	-3.4%	-2.5%	·	-5.6%	-0.41%	-0.64%	·	-0.29%	-0.29%	0.00%	·	2.1%
ROE	-5.3%	-1.5%	·	-8.6%	-11.3%	-8.4%	·	-22.9%	-1.6%	-2.6%	·	-1.3%	-1.3%	-0.01%	·	11.0%
ROIC	-4.3%	-0.47%	·	-7.6%	-11.2%	-8.3%	·	-19.5%	-0.85%	-2.0%	·	-1.1%	-0.99%	0.07%	·	9.9%

Liquidity & Solvency 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	4.1	5.9	·	5.3	5.2	6.0	·	10.7	10.0	11.3	·	9.0	9.3	6.1	·	7.2
Quick Ratio	2.6	4.7	·	4.3	4.3	5.0	·	9.6	8.9	10.1	·	8.0	8.4	5.5	·	6.3
Debt / Equity	0.7	1.1	·	1.2	1.1	1.0	·	1.5	1.2	1.3	·	1.0	1.0	1.0	·	1.0
LT Debt / Equity	0.7	1.1	·	1.2	1.1	1.0	·	1.5	1.2	1.3	·	1.0	1.0	1.0	·	1.0
Interest Coverage	·	·	·	·	·	·	·	-12.4	-0.8	-1.7	·	-1.3	-1.7	0.2	·	37.3

Efficiency 3

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.1
Inventory Turnover	0.7	0.7	·	0.8	0.8	0.8	·	0.7	0.8	0.7	·	0.7	0.8	0.6	·	0.6
Receivables Turnover	1.7	2.1	·	1.6	1.4	1.4	·	1.7	1.7	1.4	·	0.8	0.8	0.9	·	2.1

Per Share 3

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue / Share	$0.35	$0.45	·	$0.29	$0.33	$0.33	·	$0.46	$0.54	$0.48	·	$0.51	$0.52	$0.60	·	$1.45
Cash Flow / Share	·	$0.06	·	·	·	$-0.07	·	·	·	$-0.06	·	·	·	$0.65	·	·
EPS (TTM)	$-0.52	$-0.71	·	$-0.87	$-1.37	$-1.17	·	$-1.64	$-1.01	$-0.99	·	$0.20	$0.59	$1.17	·	$1.81

Valuation (TTM) 4

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$209M	$205M	·	$192M	$220M	$242M	·	$277M	$275M	$274M	·	$420M	$544M	$718M	·	$907M
Net Income TTM	$-77M	$-105M	·	$-121M	$-193M	$-163M	·	$-225M	$-134M	$-131M	·	$25M	$75M	$153M	·	$238M
P/E	-12.0	-4.0	·	-3.3	-1.8	-1.9	·	-5.1	-7.1	-8.8	·	50.0	21.1	12.0	·	14.1
Earnings Yield	-8.3%	-25.1%	·	-30.3%	-56.9%	-52.9%	·	-19.7%	-14.1%	-11.4%	·	2.0%	4.8%	8.3%	·	7.1%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Revenue	$186M	$259M	·	·	$289M
Gross Margin %	18.3%	·	·	·	·
Operating Margin %	-115.9%	-90.9%	·	·	-10.9%
Net Income	$-131M	$-145M	·	·	$-119M
Diluted EPS	$-0.90	$-1.05	·	·	$-0.90

Metric	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Debt / Equity	1.4	0.9	·	·	1.3
Current Ratio	6.6	7.5	·	·	8.0
Quick Ratio	5.4	6.3	·	·	7.2

Metric	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Free Cash Flow	$-71M	$-22M	·	·	$61M

Institutional owners (13F) 197 filers · $904.1M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 197

Value held $904.1M

New positions 45

Exited positions 24

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
45 (+16 vs prior Q)	24 (+1 vs prior Q)	56 (+2 vs prior Q)	59 (+6 vs prior Q)	+19.0M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
GTCR LLC	$125,736,031	20,150,005	13.91%	Shares
BlackRock, Inc.	$62,217,666	9,970,780	6.88%	Shares
BRAIDWELL LP	$54,306,227	8,702,921	6.01%	Shares
12 West Capital Management LP	$44,055,617	7,060,195	4.87%	Shares
MILLENNIUM MANAGEMENT LLC	$40,611,293	6,508,220	4.49%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$32,970,070	5,283,665	3.65%	Shares
Ophir Asset Management Pty Ltd	$30,118,596	4,826,698	3.33%	Shares
RENAISSANCE TECHNOLOGIES LLC	$28,744,504	4,606,491	3.18%	Shares
DEUTSCHE BANK AG\	$26,862,744	4,304,927	2.97%	Shares
VANGUARD GROUP INC	$23,291,216	7,166,528	2.58%	Shares
First Eagle Investment Management, LLC	$22,908,831	3,671,287	2.53%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$19,538,266	3,130,258	2.16%	Shares
STATE STREET CORP	$18,106,645	2,901,706	2.00%	Shares
Nuveen, LLC	$17,831,299	2,857,580	1.97%	Shares
JPMORGAN CHASE & CO	$16,572,842	2,593,559	1.83%	Shares
TWO SIGMA INVESTMENTS, LP	$14,076,317	2,255,820	1.56%	Shares
Monaco Asset Management SAM	$13,921,602	2,231,026	1.54%	Shares
PRUDENTIAL FINANCIAL INC	$13,429,441	2,152,154	1.49%	Shares
CITADEL ADVISORS LLC	$13,245,011	2,122,598	1.47%	Shares
Point72 Asset Management, L.P.	$12,514,813	2,005,579	1.38%	Shares
MORGAN STANLEY	$11,907,642	1,908,276	1.32%	Shares
Philosophy Capital Management LLC	$11,856,000	1,900,000	1.31%	Shares
TUDOR INVESTMENT CORP ET AL	$11,538,253	1,849,079	1.28%	Shares
ROYCE & ASSOCIATES LP	$11,284,716	1,808,448	1.25%	Shares
GENERAL AMERICAN INVESTORS CO INC	$10,709,044	1,716,193	1.18%	Shares
Hillsdale Investment Management Inc.	$10,501,159	1,682,878	1.16%	Shares
SYSTEMATIC FINANCIAL MANAGEMENT LP	$10,394,704	1,665,817	1.15%	Shares
GOLDMAN SACHS GROUP INC	$10,241,693	1,641,297	1.13%	Shares
Tejara Capital Ltd	$9,954,953	1,595,345	1.10%	Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$9,444,901	1,513,606	1.04%	Shares
MARSHALL WACE, LLP	$9,182,019	1,471,477	1.02%	Shares
DIMENSIONAL FUND ADVISORS LP	$8,497,695	1,361,558	0.94%	Shares
ArrowMark Colorado Holdings LLC	$7,956,000	1,275,000	0.88%	Shares
Point72 (DIFC) Ltd	$7,430,106	2,588,887	0.82%	Shares
KENNEDY CAPITAL MANAGEMENT LLC	$6,910,045	1,107,379	0.76%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$6,686,385	1,071,536	0.74%	Shares
JACOBS LEVY EQUITY MANAGEMENT, INC	$6,417,085	1,028,379	0.71%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$6,290,588	1,008,107	0.70%	Shares
NORTHERN TRUST CORP	$6,242,247	1,000,360	0.69%	Shares
First Pacific Advisors, LP	$5,521,670	884,883	0.61%	Shares
VANGUARD FIDUCIARY TRUST CO	$5,136,263	823,119	0.57%	Shares
BNP PARIBAS FINANCIAL MARKETS	$4,948,083	792,962	0.55%	Shares
Verition Fund Management LLC	$4,853,085	777,738	0.54%	Shares
Qube Research & Technologies Ltd	$4,670,309	748,447	0.52%	Shares
Decker Retirement Planning Inc.	$3,849,337	616,881	0.43%	Shares
Invesco Ltd.	$3,570,279	572,160	0.39%	Shares
NORGES BANK	$3,540,576	567,400	0.39%	Shares
BANK OF AMERICA CORP /DE/	$3,304,379	529,548	0.37%	Shares
Cerity Partners LLC	$2,928,800	469,359	0.32%	Shares
TWO SIGMA ADVISERS, LP	$2,849,275	876,700	0.32%	Shares

Show all 197 institutional owners →

Company insiders 25 insiders · 13 officers · 13 directors

19

Insider	Role	Last activity	Shares owned	Buys 12m	Sells 12m	Net 12m
Bernd Brust	Chief Executive Officer	Sept. 8, 2026 F	1,561,249	3	0	$1,511,699
William E. Martin III	Chief Executive Officer	March 17, 2025 A	1,814,643	0	0	$0
Rajesh Asarpota	Chief Financial Officer	Sept. 30, 2026 F	418,021	0	0	$0
Kevin Herde	Chief Financial Officer	May 15, 2025 A	674,636	0	0	$0
Andrew Burch	Former President, Nucleic Acid Production	Jan. 15, 2025 F	369,183	0	0	$0
Eric Tardif	President	Nov. 19, 2020 A	·	0	0	$0
Brian Neel	Chief Operating Officer, Nucleic Acid Production	Feb. 15, 2023 F	16,473	0	0	$0
Lisa Sellers	Chief Operating Officer, Protein Detection	Nov. 24, 2020 P	18,888	0	0	$0
Kurt Oreshack	General Counsel	June 10, 2026 S	335,767	0	2	$-254,000
Christine Dolan	Executive Vice President & General Manager, Cygnus Technologies	May 15, 2026 A	425,318	0	0	$0
Peter Michael Leddy	Chief Administrative Officer	July 15, 2025 F	727,177	0	0	$0
Rebecca Buzzeo	Chief Commercial Officer	March 17, 2025 A	606,791	0	0	$0
Carl Hull	Executive Chairman	Nov. 11, 2024 P	175,000	0	0	$0
Gregory T Lucier	Director	June 9, 2026 G	156,077	2	0	$368,544
Susannah Gray	Director	May 26, 2026 A	216,200	0	0	$0
Luke Joseph Marker	Director	May 26, 2026 A	184,348	0	0	$0
Sean Laurence Cunningham	Director	May 26, 2026 A	184,348	0	0	$0
John A Deford	Director	May 26, 2026 A	205,478	0	0	$0
Andrew R Eckert	Director	May 26, 2026 A	412,183	0	0	$0
Murali Prahalad	Director	June 16, 2025 A	154,607	0	0	$0
Benjamin James Daverman	Director	June 16, 2025 A	138,055	0	0	$0
Jessica Hopfield	Director	June 16, 2025 A	199,907	0	0	$0
Anat Ashkenazi	Director	May 23, 2024 A	60,768	0	0	$0
Robert B Hance	Director	Nov. 19, 2021 A	26,123	0	0	$0
Constantine S Mihas	·	May 26, 2026 A	184,348	0	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 19 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
IBBQ · Invesco Exchange-Traded Fund Trust …	0.07%	10,546 SH	Oct. 1, 2026	Daily
IBB · iShares Trust	0.05%	804,353 SH	Sept. 11, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.05%	179,599 SH	Oct. 2, 2026	Daily
VTWV · VANGUARD SCOTTSDALE FUNDS	0.04%	98,331 SH	Aug. 19, 2026	Daily
IWM · iShares Trust	0.03%	2,915,565 SH	Sept. 11, 2026	Daily
RSSL · Global X Funds	0.02%	53,877 NS	July 31, 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0.02%	649,581 SH	Aug. 19, 2026	Daily
DFAS · Dimensional ETF Trust	0.01%	285,768 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.01%	1,454,980 SH	Aug. 19, 2026	Daily
VHT · VANGUARD WORLD FUND	0.01%	315,518 SH	Aug. 19, 2026	Daily
WSML · iShares Trust	0.01%	7,056 SH	Sept. 11, 2026	Daily
DFSU · Dimensional ETF Trust	0.00%	8,779 NS	July 31, 2026	N-PORT
DCOR · Dimensional ETF Trust	0.00%	10,921 NS	July 31, 2026	N-PORT
ITOT · iShares Trust	0.00%	209,371 SH	Sept. 11, 2026	Daily
IWV · iShares Trust	0.00%	30,689 SH	Sept. 10, 2026	Daily
DFAC · Dimensional ETF Trust	0.00%	14,388 NS	July 31, 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0.00%	3,706,103 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	8,106 SH	Aug. 19, 2026	Daily
IWN · iShares Trust	·	1,068,761 SH	Sept. 11, 2026	Daily

MRVI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 15 analysts BUY

Median target $8.00 +1.3%

4 26.7% Strong Buy

6 40.0% Buy

5 33.3% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

5 analysts · 2026-10-03

Mean target $7.60 -3.8%

Now Current price $7.90

Low$7.00 Mean$7.60 High$8.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
MRVI	·	-3.6	-28.3%	-70.4%	-48.6%	18.3%
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·
ALMR	·	·	·	·	·	·
FTRE	$1.61B	-1.6	1.0%	-36.2%	-171.1%	·
BLFS	·	-241.8	28.9%	·	·	·
PSNL	$816M	-8.7	-17.7%	-116.7%	-36.0%	·
AZTA	$1.32B	-23.5	3.5%	-9.4%	-3.3%	45.5%
CYRX	$479M	6.9	12.4%	44.4%	15.3%	47.1%

Latest News Recent headlines mentioning this company

23

Maravai (MRVI) Q1 2026 Earnings Transcript Yahoo Finance · 4 months, 3 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

MRVI Class A Maravai LifeSciences Holdings, Inc. - Class A common stock